NCT02732899View on ClinicalTrials.gov

Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

March 20, 2017

Study Completion Date

April 4, 2017

Conditions
Exudative Age Related Macular Degeneration
Interventions
DRUG

Sirolimus

DRUG

EYLEA

Trial Locations (1)

46290

Raj K Maturi MD PC, Indianapolis

All Listed Sponsors
lead

Maturi, Raj K., M.D., P.C.

INDIV

NCT02732899 - Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD | Biotech Hunter | Biotech Hunter